asthmat
suscept
influenza
infect
yet
mechan
mediat
enhanc
suscept
unknown
influenza
viru
hemagglutinin
ha
protein
bind
sialic
acid
residu
host
cell
ha
requir
cleavag
allow
fusion
viral
ha
host
cell
membran
mediat
host
trypsinlik
serin
proteas
show
data
demonstr
proteas
antiproteas
ratio
increas
nasal
mucosa
asthmat
chang
associ
increas
proteolyt
activ
influenza
data
suggest
disrupt
proteas
balanc
asthmat
enhanc
activ
infect
influenza
viru
viral
hemagglutinin
ha
protein
express
influenza
virion
surfac
respons
bind
sialic
acid
residu
host
cell
fusion
viru
membran
host
cell
occur
ha
proteolyt
cleav
wherea
virion
uncleav
ha
noninfecti
cleavag
host
trypsinlik
serin
proteas
two
protein
fragment
produc
proteas
turn
regul
mucu
antiproteas
secretori
leukocyt
proteas
inhibitor
slpi
antitrypsin
group
recent
demonstr
human
nasal
epitheli
cell
nec
secret
cellular
proteas
transmembran
proteas
serin
antiproteas
slpi
oxidantinduc
disrupt
proteaseantiproteas
balanc
character
increas
express
secret
result
increas
ha
cleavag
viral
replic
asthmat
suscept
respiratori
viral
infect
thought
increas
oxid
stress
hypothes
disrupt
proteaseantiproteas
balanc
airway
result
increas
influenza
viral
cleavag
replic
subject
allerg
asthma
aa
sinc
nasal
passag
primari
site
infect
sever
common
virus
includ
influenza
character
proteaseantiproteas
balanc
nasal
lavag
fluid
nlf
healthi
volunt
hv
aa
subject
recruit
sampl
collect
analyt
techniqu
ident
recent
report
demograph
data
total
subject
hv
aa
present
tabl
cellfre
nlf
hv
aa
use
character
differ
proteaseantiproteas
express
influenza
ha
cleavag
viral
replic
normal
total
protein
concentr
present
cellfre
nasal
lavag
immunoblot
reveal
compar
hv
slpi
express
decreas
level
proteas
increas
aa
figur
provid
quantit
analysi
differ
present
data
averag
proteaseantiproteas
balanc
hv
specif
densitometr
analysi
slpi
use
calcul
ratio
slpi
figur
result
indic
aa
display
disrupt
proteaseantiproteas
balanc
nasal
surfac
liquid
favor
proteas
express
determin
proteas
present
apic
surfac
liquid
nasal
lavag
function
cleav
intact
influenza
virion
nlf
total
protein
incub
influenza
subsequ
analyz
variou
form
ha
use
immunoblot
figur
show
nlf
hv
aa
abl
cleav
product
nlf
aa
increas
proteolyt
activ
similar
previou
studi
examin
whether
nlf
aa
hv
differ
abil
produc
infecti
virion
use
modifi
infect
viral
titer
assay
experi
determin
whether
secret
proteas
present
nlf
hv
aa
abl
facilit
multipl
round
viral
replic
madindarbi
canin
kidney
cell
mdck
requir
exogen
ad
proteas
becom
infect
replic
influenza
viru
nlf
hv
aa
incub
influenza
mock
control
ad
mdck
cell
analysi
influenza
viral
titer
figur
show
secret
proteas
nlf
healthi
volunt
abl
activ
influenza
virion
lead
viral
entri
replic
mdck
cell
effect
increas
nlf
aa
taken
togeth
result
demonstr
nlf
aa
disrupt
secret
proteas
antiproteas
balanc
use
exact
sampl
also
demonstr
viru
incub
nlf
aa
display
signific
increas
influenza
viru
cleavag
replic
mdck
cell
conclus
first
studi
demonstr
secret
proteas
nlf
human
proteolyt
activ
influenza
virion
activ
enhanc
aa
specul
disrupt
epitheli
proteaseantiproteas
balanc
aa
plausibl
riskfactor
increas
suscept
individu
influenza
infect
potenti
virus
sarscov
metapneumoviru
also
requir
proteolyt
activ
author
declar
compet
interest
author
contribut
mk
design
carri
studi
analyz
data
draft
manuscript
mh
contribut
clinic
character
recruit
subject
popul
ij
contribut
design
oversaw
coordin
overal
studi
final
manuscript
author
read
approv
final
manuscript
project
describ
part
support
nation
institut
health
grant
mh
nation
institut
environment
health
scienc
ij
nation
heart
lung
blood
institut
ij
